<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chowdhury S</submitter><funding>Council of Scientific and Industrial Research</funding><funding>Council of Scientific and Industrial Research (CSIR)</funding><pagination>405</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11405666</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>Derangements in protein homeostasis and associated proteotoxicity mark acute, chronic, and drug-induced hepatocellular injury. Metabolic dysfunction-associated proteasomal inhibition and the use of proteasome inhibitors often underlie such pathological hepatic proteotoxicity. In this study, we sought to identify a candidate deubiquitinating enzyme (DUB) responsible for reversing the proteotoxic damage. To this end, we performed a siRNA screening wherein 96 DUBs were individually knocked down in HepG2 cells under proteasomal inhibitor-induced stress for dual readouts, apoptosis, and cell viability. Among the putative hits, we chose JOSD1, a member of the Machado-Josephin family of DUBs that reciprocally increased cell viability and decreased cell death under proteotoxicity. JOSD1-mediated m</pubmed_abstract><journal>Cell death discovery</journal><pubmed_title>Deubiquitinase JOSD1 tempers hepatic proteotoxicity.</pubmed_title><pmcid>PMC11405666</pmcid><funding_grant_id>MLP138</funding_grant_id><pubmed_authors>Das D</pubmed_authors><pubmed_authors>Chowdhury S</pubmed_authors><pubmed_authors>Chakrabarti P</pubmed_authors><pubmed_authors>Sen A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Deubiquitinase JOSD1 tempers hepatic proteotoxicity.</name><description>Derangements in protein homeostasis and associated proteotoxicity mark acute, chronic, and drug-induced hepatocellular injury. Metabolic dysfunction-associated proteasomal inhibition and the use of proteasome inhibitors often underlie such pathological hepatic proteotoxicity. In this study, we sought to identify a candidate deubiquitinating enzyme (DUB) responsible for reversing the proteotoxic damage. To this end, we performed a siRNA screening wherein 96 DUBs were individually knocked down in HepG2 cells under proteasomal inhibitor-induced stress for dual readouts, apoptosis, and cell viability. Among the putative hits, we chose JOSD1, a member of the Machado-Josephin family of DUBs that reciprocally increased cell viability and decreased cell death under proteotoxicity. JOSD1-mediated m</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2025-04-05T18:45:16.888Z</modification><creation>2025-04-05T18:45:16.888Z</creation></dates><accession>S-EPMC11405666</accession><cross_references><pubmed>39284830</pubmed><doi>10.1038/s41420-024-02177-y</doi></cross_references></HashMap>